Noxopharm is an Australian publicly-listed (ASX: NOX) clinical stage drug development company.

Biotechnology

Noxopharm Limited

Noxopharm Limited's headquarters in Gordon, Australia

Gisela Mautner

M.D.-Ph.D. Dr Gisela Mautner Mph, Mba, Facpe, Maicd, Fiidm, Cceo

Olivier Laczka

Shawn Van Boheemen

Boris Patkin

David Franks

Frederick Bart

Peter Marks

The Leadership Team at Noxopharm Limited is responsible for guiding the strategic direction of the company, overseeing clinical development programs, and ensuring operational efficiency. This team collaborates to drive innovation in drug development, manage financial health, and foster a culture of research excellence, ultimately aiming to deliver transformative therapies for patients in need.

Leadership Team

The Research and Development team at Noxopharm Limited focuses on advancing novel drug therapies for cancer and inflammatory diseases. Led by experienced Chief Scientific Officers and clinical operations experts, the team conducts preclinical and clinical trials to evaluate the safety and efficacy of potential treatments, while also optimizing pharmaceutical formulations to ensure their success in the market.

Noxopharm Limited

Org chart

Board & advisors

Teams

Leadership Team

Research and Development

Offices

Noxopharm Limited

Org chart

Board & advisors

Teams

Leadership Team

Research and Development

Offices

Related companies